CDC's vaccine advisory panel recommends limiting hepatitis B immunization at birth to infants born to hepatitis B positive or unknown status mothers, revising a 30+ year-old universal policy. The decision reflects shifting vaccine guidance and ongoing debates on vaccine safety and dosing.